| PGBEX | RGAHX | PGBEX / RGAHX | |
| Total Expense Ratio | 1.13 | 0.44 | 257% |
| Annual Report Gross Expense Ratio | 1.16 | 0.44 | 264% |
| Fund Existence | 10 years | 10 years | - |
| Gain YTD | -9.201 | 9.109 | -101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.91B | 339B | 3% |
| Annual Yield % from dividends | 0.00 | 0.44 | - |
| Returns for 1 year | -11.50 | 5.91 | -195% |
| Returns for 3 years | 47.23 | 67.08 | 70% |
| Returns for 5 years | 18.45 | 23.08 | 80% |
| Returns for 10 years | N/A | 94.58 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CICAX | 62.96 | 0.03 | +0.05% |
| American Funds Invmt Co of Amer 529A | |||
| QILGX | 43.06 | 0.01 | +0.02% |
| Federated Hermes MDT Large Cap Growth IS | |||
| FPHAX | 32.21 | N/A | N/A |
| Fidelity Select Pharmaceuticals Port | |||
| GMCUX | 16.99 | N/A | N/A |
| Goldman Sachs Small/Mid Cap Equity R6 | |||
| VBCVX | 16.81 | -0.02 | -0.12% |
| VALIC Company I Systematic Value | |||